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Abstract
Objectives After intraarterial recanalisation (IAR), the haemor-
rhage and the blood-brain barrier (BBB) disruption can be dis-
tinguished using dual-energy computed tomography (DECT).
The aim of the present study was to investigate whether future
infarction development can be predicted from DECT.
Methods DECT scans of 20 patients showing 45 BBB
disrupted areas after IAR were assessed and compared with
follow-up examinations. Receiver operator characteristic
(ROC) analyses using densities from the iodine map (IM)
and virtual non-contrast (VNC) were performed.
Results Future infarction areas are denser than future non-
infarction areas on IM series (23.44±24.86 vs. 5.77±2.77;
p < 0.0001) and more hypodense on VNC series (29.71
± 3.33 vs. 35.33± 3.50; p<0.0001). ROC analyses for the
IM series showed an area under the curve (AUC) of 0.99
(cut-off: <9.97 HU; p<0.05; sensitivity 91.18 %; specificity
100.00 %; accuracy 0.93) for the prediction of future infarc-
tions. The AUC for the prediction of haemorrhagic infarctions
was 0.78 (cut-off >17.13 HU; p<0.05; sensitivity 90.00 %;
specificity 62.86 %; accuracy 0.69). The VNC series allowed
prediction of infarction volume.
Conclusions Future infarction development after IAR can be
reliably predicted with the IM series. The prediction of
haemorrhages and of infarction size is less reliable.
Key Points
• The IM series (DECT) can predict future infarction develop-
ment after IAR.
• Later haemorrhages can be predicted using the IM and the
BW series.
• The volume of definable hypodense areas in VNC correlates
with infarction volume.
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Introduction
Dual-energy computed tomography (DECT) is a novel meth-
od based on the application of radiation with two different
energies that allows different materials with similar densities
to be distinguished on conventional computed tomography
(CT) [1–4]. For example, haemorrhage can be distinguished
from blood-brain barrier (BBB) disruptions or from a mixture
of haemorrhage and BBB disruption in different situations
[4–11]. Immediately after intraarterial recanalisation (IAR) it
is extremely important to detect and distinguish reliably be-
tween intracranial haemorrhage and BBB disruptions. This is
in order to begin prevention safely of a new ischemic event in
patients with no haemorrhage [12] with antiplatelet therapy
[13], which is too dangerous in patients with haemorrhage.
However, in most cases, hyperdensities immediately after
EST represent non-haemorrhagic BBB disruptions [9, 10];
an ischemic infarction may or may not be present, but cannot
be diagnosed under these conditions. Haemorrhages may or
may not occur in these infarctions in the future, which also
cannot be predicted. The larger an infarction is, the more likely
it is that there will be haemorrhages later [14]. It is, therefore,
also important to detect or predict an infarction under these
circumstances and estimate it’s size as soon as possible.
Newer approaches consist of combining rapid reperfusion
using IAR with vasculoprotective and neuroprotective treat-
ment in order to improve the outcome even more [15].
Reperfusion and stabilization of the neurovascular unit and
BBB must be integrated to prevent adverse reperfusion dam-
age [16]. This combination was recently tested in the URICO-
ICTUS trial [17] with promising results. However, despite all
efforts to provide the best possible acute treatment, infarctions
or haemorrhagic infarctions may still develop later. The first
group benefits from secondary prevention of a new stroke
[13], while in the latter group, no prostaglandin H2 synthase
inhibitors such as aspirin or the like must be administered.
The aim of the present study was to investigate whether
DECT, performed immediately after IAR, can be used to pre-
dict the future tissue development of non-haemorrhagic BBB
disrupted areas.
Materials and methods
This retrospective study was approved by the local ethical
review board (AN2014-0158-337/4.6). Twenty patients (nine
women and 11 men; with a mean age of 64.45±14.99 years,
range: 24 to 89 years) with a major stroke and the need for
endovascular therapy were included. All patients received a
DECT scan within 1 h after endovascular stroke therapy, and
all patients displayed a BBB disruption in one or more areas
(n=45). No haemorrhagic transformation was present in these
areas. During the study period of 2 years, 14 patients who
received DECT after EST were excluded due to apparent
haemorrhage.
BBB disrupted areas
The BBB disrupted areas were the putamen in 13 (28.9 %)
cases, caudate nucleus in eight (17.8 %), insular cortex in
eight (17.8 %), thalamus in seven (15.6 %), a peripheral part
of the parietal or frontal lobe in three (6.7 %), part of the
occipital lobe in three (6.7 %), part of the cerebellum in two
(4.4 %), and part of the pons in one (2.2 %). All 45 regions
were discontiguous. To be counted separately as a region with
a BBB rupture, the region has to be clearly separated from the
others by tissue with no BBB rupture.
Dual-energy computed tomography
The DECT scans were performed using a SOMATOM
Definition Flash CT scanner (Siemens Healthcare GmbH,
Erlangen, Germany) with tube voltages of 100 and 140 kVp
and a fixed current of 324 mA for both tubes. The dosage was
2.3± 0.1 mSv. This was a standard DECT protocol recom-
mended by the vendor. The datasets were reconstructed with
1 mm slice thickness, 0.8 mm increment, H40f medium ker-
nel, base orbit window, and a 200-mm field of view. A 50% to
50 % weighted standard “brain window” (BW) series was
reconstructed (slice thickness: 4 mm, increment: 4 mm, ker-
nel: H30f medium smooth, field of view: 200 mm).
Corresponding iodine map (IM) series and virtual non-
contrast (VNC) series were reconstructed using the post-
processing software “Brain Hemorrhage” (syngo CT
Workplace 2012B, Siemens Healthcare GmbH, Erlangen,
Germany). A H30f medium smooth kernel was also used for
this.
Image evaluation
Non-haemorrhagic BBB disruption was defined as BW and
IM hyperdensity accompanied by VNC hypo- or isodensity,
according to Tijssen et al. [10]. These areas were estimated by
consensus of two raters who also later performed the density
measurements and the volumetries of the areas involved.
The density measurements in Hounsfield units (HU) on the
BW, the IM, and the VNC series (Fig. 1) were performed by
two neuroradiologists (TD and AEG) independently, using
circular ROI measurements in each of the one to four affected
areas per patient. The ROI size was adapted to the size of the
area –maximum 1 cm2 – on a PACS workstation (IMPAX EE
R20 XIV, Agfa, Mortsel, Belgium). Both raters were blinded
with respect to the follow-up imaging and to each other. First,
three ROIs were placed in the BBB disrupted area in the IM
series to represent different parts of the area especially in large
areas without touching its edges. Then the three IMROIs were
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automatically copied on the BM and VNC series. All mea-
surements were repeated by the two raters several weeks later.
Only in cases in which an infarction was detected in the
follow-up images, but the abnormalities in the region were ill
defined in the imagesmade immediately after the intervention,
were the ROIs placed retrospectively in the later infarction
with knowledge of the follow-up images (n =4). Then the
follow-up imaging was analyzed by the same raters.
Differences were decided by consensus and a third rater (BG).
The later fate of the 45 areas was investigated on follow-up
MRI (n=10; including susceptibility weighed imaging series;
SWI; MAGNETOM Skyra, Siemens Healthcare GmbH,
Erlangen, Germany) or CTscans (n=10) during the first week
after the event. Follow-up imaging was performed between
24 h and 7 days after the treatment. The areas were allocated
to the three groups: “no infarction”, “ischemic infarction”, and
“haemorrhagic infarction”. “No infarction” was defined as
normal brain tissue in every sequence on the follow-up scans,
“ischemic infarction” as detectable brain cell death [18], and
“haemorrhagic infarction” according to the ECASS definition
[19].
In a last step, the volumes of the BBB disrupted or con-
spicuous areas and the infarctions in the follow-up controls
were determined by each rater in each series using an AW
workstation version 5 [AW VolumeShare 5 (AW4.6),
General Electric Company, Fairfield, CT, USA]. After a few
days, these volumetries were repeated.
Clinical and procedure related parameters
The modified Rankin and National Institute of Health Stroke
scores, immediately after admission and 90 days after the
event, were determined and noted. The time to IAR onset,
duration of IAR procedure, etc., are presented in Table 1.
The following devices were used: 15 times Solitaire
(Solitaire 2, ev3 Neurovascular, Irvine, CA, USA), six times
ERIC (ERIC 3, MicroVention, Inc., Tustin, CA, USA), five
times ReVive (ReVive SE, Codman, Johnson & Johnson
Corp., New Brunswick, NJ, USA), twice pRESET
(pRESET, Phenox GmbH, Bochum, Germany), and once a
Trevo (Trevo XP, Concentric Medical, Mountain View, CA,
USA).
Statistical analysis
Descriptive analyses were performed using the Excel software
(Microsoft Office 2013, Microsoft Corp., Redmond, WA,
USA); the Prism 6 software (GraphPad Prism 6, GraphPad
Software, Inc., La Jolla, CA, USA) was used for further sta-
tistical analyses and presentation. Intra- and inter-rater reliabil-
ities were calculated using the intraclass correlation coefficient
[20] (SPSS 23, IBM Corp., Armonk, NY, USA). A kappa
coefficient (SPSS) was used to estimate the intra-observer
reliability of the categorical variable “infarction/no infarc-
tion”. As the data were not entirely normally distributed, the
cba
fed
Fig. 1 a–f Example of a patient
with a left cerebellar
haemispheric infarction
(blue arrow) and a left pontine
infarction (violet arrow), which
became haemorrhagic 2 days after
the IAR. The infarctions are
hyperdense on BW series
(Figure 1a), hyperdense on IM
series (Figure 1b), hypodense on
VNC series (Figure 1c),
hyperintense on diffusion
weighted imaging (DWI B1000,
Figure 1d), hypointense on the
apparent diffusion coefficient





Figure 1f) in the follow-up
imaging
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non-parametric Mann-Whitney test for the comparison
of two groups, and the Kruskal-Wallis test together with
Dunn’s post hoc test for the comparison of three or
more groups were used. The Spearman method was
used to test for correlations between two groups. The
effectiveness of the different reconstruction algorithms
was assessed using receiver operating characteristic
(ROC) analyses. Cut-off points for decision-making
using the BW, IM, and VNC series were determined
according to Youden’s method [21]. True positive
(TP), true negative (TN), false positive (FP), and false
negative (FN) results, sensitivity, specificity, positive
predictive value, negative predictive value, accuracy,
and AUC were determined. Accuracy was defined as
follows:
Accuracy ¼ TP þ TN
TP þ FP þ TN þ FN
The significance of the deviation of AUC from the others
was determined using the method of Venkatraman, or a
bootstrapped method, as appropriate in the pROC package
in R (R version 3.2.4) [22, 23]. A p<0.05 was regarded to
be significant.
Results
All BBB disrupted areas were within the regions treated with
IAR. Pre-interventional hypodense areas consistent with early
signs of infarctions were found retrospectively in the CT in
two regions. Both of these regions were in infarction areas that
were later very extensive, but not affected by haemorrhagic
transformation.
Of the 45 investigated areas, 11 (22.2 %) were unsuspi-
cious on follow-up scans, 24 (55.5 %) became ischemic in-
farctions, and 10 (22.2 %) ischemic infarctions with
haemorrhagic transformation. The inter-rater reliability of
the estimate with respect to the presence of haemorrhage
was perfect (kappa=1), that with respect to the presence of
an infarction in the follow-up scans was very good (kap-
pa=0.886). Detailed information about the patients and the
procedures is presented in Table 1. The intra- and inter-rater
reliability are presented in Table 2, the density measurement
results and the results of the volumetries in Table 3.
In the IM (Fig. 2a and b) and the BW series (Fig. 2c and d),
future non-infarction areas displayed significantly lower den-
sities than future ischemic or haemorrhagic infarction areas
and in the VNC series (Fig. 2e and f), future normal brain
tissue areas displayed higher densities than ischemic or
haemorrhagic infarction areas.
Significantly different densities between the groups “no
infarction” and “ischemic infarction” as well as the groups
“no infarction” and “haemorrhagic infarction”, but not be-
tween the groups “ischemic infarction” and “haemorrhagic
infarction” in the IM series (Fig. 3a and b), the BW series
(Fig. 3c and d), and the VNC series (Fig. 3e and f) were found.
Neither the quantity of contrast agent injected during the
angiography nor any other factor measured correlated signif-
icantly with the densities measured in the individual series
(Spearman’s ρ≈0.2 each, p>0.05 each). In the patients who
had had anMRI as a follow-up examination, the same number
of infarctions was found as in the patients who had had a CT
follow-up examination (2.1±1.29 versus 2.4±0.97, p>0.05).
Table 1 Procedure related parameters
Variable
Time to lysis (min) 91.89 ± 54.17
Time to recanalisation (min) 88.26 ± 55.58
Time to IAR (min) 163.94 ± 52.17
Duration of IAR (min) 85.85 ± 52.54
Device passes per procedure 2.68 ± 1.86
Diameter of BBBD area (mm) 17.99 ± 7.91
Contrast agent (mL) 202.63 ± 84.12
NHISS admission 19.00 ± 7.31





Stent, Balloon, ia-Thrombolysis 1
Device combinations used
Eric 2















Abbreviations: BBBD, Blood brain barrier disruption; ia, Intraarterial;
IAR, Intraarterial Recanalisation; iv, Intravenous; mL, millilitres; mRS,
modified Rankin Scale; NHISS, National Institutes of Health Stroke
Scale; TICI, Thrombolysis in cerebral infarction scale
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The ROC analyses of the IM densities for the differentia-
tion between future infarction areas and non-infarction areas
(Fig. 4a and b) revealed an AUC of 0.9947±0.00718 (CI:
0.98061-1.009; p < 0.0001) for reader 1 and an AUC of
0.9786±0.01732 (CI: 0.9447-1.013; p<0.0001) for reader
2. The density cut-off value for discrimination was >10.4
HU for reader 1 and >10.3 HU for reader 2. Using these
densities, the sensitivity reached 94.12 % for reader 1 and
88.24 % for reader 2, and the specificity was 100 % for both
readers. The accuracy of the test was 0.96 for reader 1, and
0.91 for reader 2. The values for the VNC series and the BW
series and the summarized values of both raters are presented
in Table 3.
The ROC analyses for the differentiation between the fu-
ture haemorrhagic and non-haemorrhagic infarctions are
shown in Fig. 4c and d, the ROC analyses for the prediction
of the size of infarctions are shown in Fig. 4e and f, and the
measures of performance are shown in Table 3.
Discussion
In the present cohort of patients with BBB disrupted areas
after IAR, approximately one quarter of these areas did not
become infarctions, whereas the other areas evolved either to
ischemic or haemorrhagic infarctions. Future infarction areas
were found to be denser than future non-infarction areas in the
BW and IM series and more hypodense in VNC series.
The iodine map allowed extremely good differentiation
between future infarction areas and non-infarction areas, with
an AUC of 0.99 for rater 1 and an AUC of 0.98 for rater 2. The
cut-off value for discrimination was >10.4 HU for reader 1
and >10.3 HU for reader 2, with a sensitivity of 94.12 %/
88.24 % and a specificity of 100 %/100 % (Table 3). The
BW and the VNC series are of lower value for this purpose.
For the prediction of a future haemorrhagic transformation,
IM was slightly, but not statistically significantly superior to
the BW series with a cut-off of >17.9 HU for rater 1 and
>13.19 HU for rater 2 and an AUC of 0.76 for rater 1 and
0.8 for rater 2. Both series are of moderate to good value for
this purpose. The volume of an infarction can be predicted
moderately to well using the VNC series with an AUC of
0.79 (rater 1) and 0.81 (rater 2). In the IM and BW series,
intra- and inter-rater reliability was high, indicating a high
reproducibility of this method. The post-processing steps are
easy to perform, and the time required is short. Image inter-
pretation can be achieved in less than a minute.
A considerable limitation of the present study is the rela-
tively small number (45) of areas of interest. However, the
group differences detected are distinctive and highly signifi-
cant; therefore, the results appear to be reliable. In some pa-
tients early infarct signs, BBB disruptions, or haemorrhage
were only poorly demarcated on the post-interventional
DECT scan. The poor geographic demarcation due to ill-
defined or indistinct margins is reflected in the comparison
with the density measurements with low inter- and intra-
observer reliability in the volumetry of the lesions. The most
relevant limitation might be that the DECT technique is not
yet available in all centres performing IAR. Moreover, the
technique can be used with different voltages of the second
tube. While the first tube was set at a constant 140 kVp, the
voltage of the second tube fluctuates depending on the article
between 80 [5, 6, 9, 10], 120 [8], and 100 [24] kVp. It is
unclear whether this has an effect on the densities measured
in the calculated IM or VNC series or the respective reported
thresholds and could be a source of error when transferring the
technique to another device. This question could be clarified
only in a phantom study. Similarly, it is not known whether
there would be an effect on the results if instead of the H30
smooth kernel used in this study, a DE34 kernel or an H31
kernel, for example, were used for visualization. Different
kernels could not be calculated retrospectively for this study
because the raw data required for this are stored for only a few
days. Since the kernels are similar, we consider an effect to be
unlikely, which was also confirmed by the results thus far of
four patients. However, potential effects must be ruled out by
a larger number of examinations. Although the quantity of
contrast agent injected during the angiography did not corre-
late significantly with the densities in the individual series,
further studies in this respect are certainly necessary. The den-
sity of the BBB disrupted areas likely depends primarily on
Table 2 Intra- and inter-rater reliability
Intra-rater reliability (ICC) - Density
Rater 1 p Rater 2 p
BW 0.858 <0.001 0.984 <0.001
IM 0.881 <0.001 0.972 <0.001
VNC 0.795 <0.001 0.604 <0.001
Intra-rater reliability (ICC) - Volume
Rater 1 p Rater 2 p
BW 0.944 <0.001 0.933 <0.001
IM 0.947 <0.001 0.954 <0.001
VNC 0.371 0.005 0.720 <0.001
FUI 0.960 <0.001 0.998 <0.001
Inter-rater reliability (ICC)
Density R1/R2 p Volume R1/R2 p
BW 0.993 <0.001 0.880 <0.001
IM 0.990 <0.001 0.443 0.028
VNC 0.871 <0.001 0.151 0.297
FUI - - 0.985 <0.001
Abbreviations: BW, weighted brain window series; FUI, Follow-up im-
aging; ICC, Intra-class correlation coefficient; IM, Iodine map series; R1,
Reader 1; R2, Reader 2; VNC, Virtual non contrast series
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the degree of BBB disruption. However potential effects of
other parameters are conceivable. Whether the follow-up im-
aging was performed usingMRI or CTscan did not play a role
with respect to the number of the infarctions. One explanation
is that the follow-up imaging was performed such a long time
(>24 h, <7 days) after IAR that the infarctions were clearly
demarcated in the CT scans.
DECT has been described as a reliable tool for
distinguishing intracranial hemorrhage from BBB disruptions
after intravenous contrast administration [4–6, 8] or
Table 3 Measured densities and volumes
Density and volume measurements
Density Volume
Rater 1 Rater 1
ROI 1R1 ROI 2R1 ROI 3R1 Mean 1-3R1 Volume 1R1 Volume 2R1 Mean 1-2R1
BW 53.31 ± 25.76 52.57 ± 15.53 55.15 ± 31.37 53.68 ± 23.87 2.86 ± 2.29 2.90 ± 2.60 2.88 ± 2.42
IM 18.26 ± 16.37 19.40 ± 19.68 20.69 ± 29.36 19.45 ± 21.58 2.15 ± 1.87 2.02 ± 1.73 2.09 ± 1.78
VNC 31.57 ± 4.76 30.26 ± 4.75 30.72 ± 5.05 30.85 ± 4.53 1.58 ± 3.24 0.99 ± 1.67 1.29 ± 2.14
FUI - - - - 50.73 ± 84.08 64.37 ± 101.38 57.55 ± 92.42
Rater 2 Rater 2
ROI 1R2 ROI 2R2 ROI 3R2 Mean 1-3R2 Volume 1R2 Volume 2R2 Mean 1-2R2
BW 54.06 ± 24.81 53.73 ± 26.90 55.12 ± 28-84 54.30 ± 26.76 3.28 ± 3.33 3.62 ± 4.25 3.45 ± 3.75
IM 18.42 ± 21.52 18.16 ± 26.04 19.78 ± 25.91 18.79 ± 24.36 3.91 ± 5.76 3.87 ± 5.52 3.89 ± 5.58
VNC 31.16 ± 5.78 31.28 ± 4.21 31.54 ± 4.72 31.33 ± 4.23 8.54 ± 20.45 14.37 ± 32.5 11.55 ± 25.35
FUI - - - - 70.17 ± 99.10 71.80 ± 99.53 70.98 ± 99.26
Ø Rater 1/Rater 2 Ø Rater 1/Rater 2
ROI 1R1/2 ROI 2R1/2 ROI 3 R1/2 Total mean Volume 1R1/2 Volume 2R1/2 Total mean
BW 53.69 ± 25.11 53.15 ± 20.88 55.13 ± 30.00 53.99 ± 25.27 3.07 ± 2.70 3.26 ± 3.23 3.17 ± 2.98
IM 18.34 ± 18.70 18.78 ± 22.74 20.24 ± 27.51 19.12 ± 22.90 3.03 ± 3.47 2.95 ± 3.24 2.99 ± 3.32
VNC 31.37 ± 4.61 30.77 ± 4.19 31.13 ± 4.42 31.09 ± 4.13 5.06 ± 11.26 7.70 ± 16.48 6.44 ± 13.23
FUI - - - - 60.45 ± 90.44 68.08 ± 100.00 64.27 ± 95.17
Performance measures from ROC
Prediction of infarction
Rater 1
Cut-off (HU) Sensitivity (%) Specificity (%) LR True positive (%) True negative (%) Accuracy
BW >48.80 64.71 100.00 n.a. 64.71 100.00 0.73
IM >10.40 94.12 100.00 n.a. 94.12 100.00 0.96
VNC >34.05 94.12 81.82 5.176 94.12 81.82 0.91
Rater 2
Cut-off (HU) Sensitivity (%) Specificity (%) LR True positive (%) True negative (%) Accuracy
BW >46.64 82.35 90.91 9.059 82.35 90.91 0.84
IM >10.30 88.24 100.00 n.a. 88.24 100.00 0.91
VNC <31.37 67.65 90.91 7.441 67.65 90.91 0.73
Ø Rater 1/Rater 2
Cut-off (HU) Sensitivity (%) Specificity (%) LR True positive (%) True negative (%) Accuracy
BW >49.23 76.47 90.91 8.412 76.47 90.91 0.80
IM >9.97 91.18 100.00 n.a. 91.18 100.00 0.93
VNC <33.79 94.12 81.82 5.176 94.12 81.82 0.91
Prediction of haemorrhagic transformation
Rater 1
Cut-off (HU) Sensitivity (%) Specificity (%) LR True positive (%) True negative (%) Accuracy
BW >51.12 80.00 71.43 2.800 80.00 71.43 0.73
IM >17.90 90.00 65.71 2.625 90.00 65.71 0.71
VNC >28.40 100.00 37.14 1.591 100.00 37.14 0.51
Rater 2
Cut-off (HU) Sensitivity (%) Specificity (%) LR True positive (%) True negative (%) Accuracy
1107 >52.00 80.00 77.14 3.500 80.00 77.14 0.78
1107 >13.19 100.00 57.14 2.333 100.00 57.14 0.67
1107 <33.80 90.00 31.43 1.313 90.00 31.43 0.44
Ø Rater 1/Rater 2
Cut-off (HU) Sensitivity (%) Specificity (%) LR True positive (%) True negative (%) Accuracy
BW >51.21 80.00 71.43 2.800 80.00 71.43 0.73
IM >17.13 90.00 62.86 2.423 90.00 62.86 0.69
VNC <29.13 50.00 68.57 1.591 50.00 68.57 0.64
Results from receiver operator analyses (ROC)
Abbreviations: BW, Weighted brain window series; FUI, Follow-up imaging; IM, Iodine map series; LR, Likelihood ratio; VNC, Virtual non-contrast
series; ROI, region of interest; 1-3, Measurements 1, 2, and 3
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neuroendovascular therapy with intraarterial contrast admin-
istration [9, 10, 25]. Consistent with the present study, not all
BBB disrupted areas represent a later infarction [9], but all
infarctions evolved in BBB disrupted areas. However, the
present study was the first attempt to investigate the later evo-
lution of BBB disrupted areas by investigating the densities of
the different DECT series. Thus, the described method is en-
tirely novel.
In one study in which a conventional CT scan was per-
formed immediately after IAR, a differentiation could be
made between BBB disruption and BBB disruption with fu-
ture haemorrhage using a cut-off value of 50HUwith an AUC
of 0.78 [26]. This is very consistent with the results using the
assessment of the “brain window” in the present study.
Hyperdensity in one area is not necessarily associated with a







Fig. 2 a–f Scattergrams of the density means ± standard deviations in the
groups Bno infarction^ and Binfarction^ on the iodine map series for
reader 1 (Figure 2a) and reader 2 (Figure 2b), brain window series for
reader 1 (Figure 2c) and reader 2 (Figure 2d), and virtual non-contrast
series for reader 1 (Figure 2e) and reader 2 (Figure 2f). There are
significant differences between the groups (Mann-Whitney tests)






Fig. 3 a–f Scattergrams of the density means ± standard deviations in the
groups “no infarction”, “ischemic infarction”, and “haemorrhagic”
infarction on the iodine map series for reader 1 (Figure 3a) and reader 2
(Figure 3b), brain window series for reader 1 (Figure 3c) and reader 2
(Figure 3d), and the virtual non-contrast series for reader 1 (Figure 3e)
and reader 2 (Figure 3f). There are significant differences between the
groups “no infarction” and “ischemic infarction” and “no infarction” and
“haemorrhagic infarction”, but not between “ischemic infarction” and
“haemorrhagic infarction” (Kruskal-Wallis tests with Dunn’s post hoc
tests)
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poor outcome is more likely [28]. In fact, this occurred only
once in the present study. The IM series is somewhat better in
this respect than the “brain window”, while the VNC series
has no value for predicting haemorrhage.
Retrospectively, pre-interventional hypodense areas found
in the CT scan were early signs of infarction in only two re-
gions. Both were located in very extensive future infarction
regions, but were not affected by haemorrhagic transformation.
No statistical statement can be made based on these two cases.
In the present study, BBB disruptions after IARwere found
in 20 out of 34 cases (58 %), which lies within the known
range of between 24 % and 82 % of cases [9, 10, 24, 29]. In
addition, patients with BBB disruptions seem to have lower
rates of neurologic improvement, higher mortality rates, and a
higher risk of haemorrhagic complications [24, 29]. The pres-
ent study features a smaller population than these studies just
mentioned, but it is the first study to focus on the grade of







Fig. 4 a–f Receiver operating characteristic analyses. Figure 4a and b;
rater 1 and 2: Infarction prediction using densities from IM, VNC, and
BW series. The cut-off value for the prediction of an infarction is 10.4 HU
(reader 1) and 10.3 HU (reader 2). Figure 4c and d; reader 1 and 2:
Haemorrhage prediction using densities from IM, VNC, and BW series.
Figure 4e and f; reader 1 and 2: Infarction volume prediction using lesion
volumes from IM, VNC, and BW series
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only areas with BBB disruptions were investigated; therefore,
no prognostic estimations from the presence of a BBB disrup-
tion in comparison with patients with no detectable BBB dis-
ruption can be made.
All BBB disrupted areas were located in the vascular terri-
tory dependent on the treated vessel. The prediction of the
development of an infarction was less accurate with the BW
series than with the VNC and the iodine map series. A hypo-
thetical explanation for this is that all hyperdensities of various
causes are visible in the brain window: residual contrast agent
in tissue, contrast enhancements, contrast agent extravasation,
and haemorrhages. They are mixed with regions that are pos-
sibly already hypodense .
A prior study described the limitations of post intervention-
al “conventional” CT concerning the prediction of BBB dis-
ruptions evolving to haemorrhagic infarctions [30]. As de-
scribed in the present study, even with DECT it is possible
only to a limited extent to differentiate between a future in-
farction and a haemorrhagic transformed infarction. The areas
under the curve for the BW series, and the IM series were only
moderate to good. The frequency of haemorrhagic transfor-
mation in this study (22.2 %) was within the range of frequen-
cies of 10 % to 42 % reported in the literature [6, 9, 24, 31],
and it can be determined that, consistent with the literature
[32], haemorrhagic transformation occurred only in BBB
disrupted areas. Early signs of infarction in the pre-
interventional CT that present a risk factor for haemorrhagic
transformation were found in this study in only two patients,
who later developed large infarctions, but no haemorrhage.
Although both the intra-rater and the inter-rater reliability
regarding the volume of the lesions was smallest in the VNC
series and can be described as weak, the volumes of visible
hypodense areas in the VNC maps correlate with the volumes
of the ultimate infarctions. The lower VNC densities in future
infarction areas found in the present study can most likely be
explained as very early infarction demarcations so that they
can be considered the precursors of the areas determined in the
final follow-up examinations. The volume of the contrast
agent applied during the angiography did not correlate with
the densities detected, so it can be assumed that the threshold
values indicated are independent of the volumes of the quan-
tity of contrast agent within the reported range.
Taking recent developments regarding the combination of
reperfusion therapies and neuroprotective measures into con-
sideration [15–17], it seems to be even more important to
detect reperfusion injuries as early as possible and to be able
not only to predict the development of an infarction, but its
volume and the probability of haemorrhage with better reli-
ability. This is all the more important because the patients in
the UI [17] study did not have any mechanical thrombectomy,
through which greater reperfusion damage is expected than
with IV thrombolysis, mainly because it cannot be initiated
until later than IV thrombolysis. Additional major efforts will
be required to be able detect or even predict reperfusion dam-
age in order to develop an individually adapted treatment
strategy for each patient’s condition.
Future infarction transformation of BBB disrupted areas
immediately after IAR can be predicted with a high accuracy
and a high reproducibility using DECT with IM reconstruc-
tions. A higher grade of BBB disruption seems to be connect-
ed with future infarction development. The IM is somewhat
better suited than the BW series for predicting a future
haemorrhagic transformation. However, the predictability of
haemorrhagic transformation is only moderate to good, as is
the predictability of the infarction volume using the VNC
series. This knowledge could help to detect patients at risk
for the development of large, malignant infarctions in the sub-
acute stage of a stroke.
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